Kraft Heinz recalls 368,000 pounds of fully cooked turkey bacon
The USDA's Food Safety and Inspection Service said the recalled turkey bacon was produced from April 25 through June 11 by Newberry, S.C.-based Kraft Heinz.
The recalled turkey bacon products were shipped to retailers throughout the United States, the British Virgin Islands and Hong Kong.
The recalled products include 12-ounce vacuum-packed products labeled 'Oscar Mayer Turkey BACON ORIGINAL' with use-by dates ranging from July 18 to Aug. 2 and the UPC label '071871548601.'
Also recalled are 36-ounce packages containing three of the 12-ounce vacuum-packed 'Oscar Mayer Turkey BACON Original' products with use-by dates ranging from July 23 to Sept. 4 with the UPC label 071871548748.
The 36-ounce three-packs also have one of three lot codes, which are RS19, RS40 or RS42.
A third recalled product is the 48-ounce four-packs of the 12-ounce vacuum-sealed packages of 'Oscar Mayer Turkey BACON ORIGINAL' with the UPC label 071871548793.
The four-packs have use-by dates ranging from July 18 to Sept. 4 and one of the three lot codes RS19, RS40 or RS42.
Product testing revealed the potential for listeria contamination, which triggered the recall.
The recalled turkey bacon products have the USDA mark of inspection printed on the front of their respective labels.
The USDA advises consumers to check for the recalled products and either throw them away or return them to the respective retailers who sold them.
Eating listeria-contaminated foods might cause listeriosis, which could cause fever, muscle aches, headaches, a stiff neck, confusion, loss of balance and convulsions, according to the USDA.
The condition often is preceded by diarrhea or other gastrointestinal problems as the invasive infection spreads through the gastrointestinal tract and beyond.
Copyright 2025 UPI News Corporation. All Rights Reserved.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Shift Towards Antibiotic Alternatives Drives Growth, New Vaccines and Diagnostics Revolutionize Poultry Health Management
The U.S. poultry medicine market, valued at USD 1.83 billion in 2024, is expected to soar to USD 3.11 billion by 2033, at a CAGR of 6.20%. High poultry consumption, reduced antibiotic use, and technological advances drive this growth. Key trends include antibiotic alternatives and efficient farming practices. U.S. Poultry Medicine Market Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "U.S. Poultry Medicine Market Size, Share & Trends Analysis Report By Species (Chicken, Turkey, Ducks), By Product (Biologics, Pharmaceuticals), By Disease Type, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2033" report has been added to U.S. poultry medicine market size was estimated at USD 1.83 billion in 2024 and is projected to reach USD 3.11 billion by 2033, growing at a CAGR of 6.20% from 2025 to 2033 The market is continuously growing, driven by high poultry consumption and market value, a shift towards antibiotic alternatives, and technological advancements in poultry healthcare. According to the USDA Economic Research Service, U.S. poultry products dominate both domestic and global meat markets, due to efficient production systems, advanced genetics, ample feed supply, and strong consumer demand. Between 2013 and 2022, broilers accounted for 67% of poultry sales, followed by eggs at 22% and turkeys at 11%, primarily for consumption. This surge in demand for poultry products directly translates into the need for efficient and sustainable poultry farming practices, necessitating comprehensive healthcare solutions to maintain the health and productivity of poultry flocks. The per capita consumption of poultry, from 2020 to 2024, is illustrated below in the chart:Growing concerns over antimicrobial resistance have prompted the U.S. poultry industry to reduce antibiotic use. Regulations like the Preservation of Antibiotics for Medical Treatment Act (PAMTA) and the Preventing Antibiotic Resistance Act (PARA) have restricted the use of medically important antibiotics in poultry and livestock. For decades, antibiotics have been widely used in livestock and poultry, as high-dose treatments for specific infections and as low-dose growth promoters in animal feed. In 2013, around 131,000 tons of antibiotics were used in food animals, a number projected to increase to nearly 200,000 tons by 2030 due to rising global demand. This shift has led to increased demand for alternative health management strategies, such as vaccines, probiotics, and herbal supplements, to ensure poultry health and in veterinary and animal nutrition technologies have significantly impacted the U.S. poultry pharmaceuticals market. The development of new vaccines, diagnostic tools, feed supplements, and other specialized healthcare products has enabled poultry producers to address a wider range of health challenges, improve flock performance, and enhance food safety. These innovations contribute to more efficient and sustainable poultry farming practices. Why should you buy this report? Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments. Competitive Landscape: Explore the market presence of key players worldwide. Future Trends: Discover the pivotal trends and drivers shaping the future of the global market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $1.83 Billion Forecasted Market Value (USD) by 2033 $3.11 Billion Compound Annual Growth Rate 6.2% Regions Covered United States Market Dynamics Market Driver Analysis High poultry consumption and market value Shift towards antibiotic alternatives Technological advancements in poultry healthcare Market Restraint Analysis Stringent regulatory compliance and approval processes U.S. Poultry Medicine Market Analysis Tools Industry Analysis - Porter's PESTEL Analysis Regulatory Framework Pricing Analysis Product Pipeline Analysis Estimated Poultry Population in U.S., 2024 Competitive Landscape Boehringer Ingelheim International GmbH Zoetis Services LLC Vaxxinova International BV Merck & Co., Inc. Elanco Ceva Sante Animale Phibro Animal Health Corporation Virbac Hipra Vetanco Kemin Industries, Inc. Market Participant Categorization Company Market Position Analysis/ Heat Map Analysis Participant's Overview Financial Performance Product Benchmarking Strategic Initiatives U.S. Poultry Medicine Market Report SegmentationSpecies Outlook (Revenue, USD Million, 2021 - 2033) Chicken Broiler Layer Turkey Ducks Others Product Outlook (Revenue, USD Million, 2021 - 2033) Biologics Vaccines Modified/ Attenuated Live Inactivated (Killed) Other Vaccines Other Biologics Pharmaceuticals Parasiticides Anti-infectives Anti-inflammatory Analgesics Others Medicated Feed Additives Disease Type Outlook (Revenue, USD Million, 2021 - 2033) Newcastle Disease Infectious Bronchitis Infectious Bursal Disease Coccidiosis Salmonella Marek's Disease Others Route of Administration Outlook (Revenue, USD Million, 2021 - 2033) Oral Injectable Topical Others Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033) Veterinary Hospitals & Clinics E-commerce Offline Retail Stores Others For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Poultry Medicine Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Newsweek
3 days ago
- Newsweek
Pickles Recall Update As FDA Issues Risk Warning
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A recall of several varieties of pickles because of container damage has been classified as having a potentially significant level of risk to consumers in Minnesota by the Food and Drug Administration (FDA). The reason for the recall last month of Gedney Foods Company's branded pickles was because products "were slated for disposal due to product and container damage, but were inadvertently sold," according to FDA reports. The recall was classified on Tuesday as a Class II, out of the three possible classes indicating the level of risk to consumers. Newsweek has contacted Gedney Foods Company outside of regular working hours via email for comment. Why It Matters The classification suggests that use of these products may cause temporary or medically reversible adverse health consequences, but that the probability of serious adverse health consequences is remote. If products are not packaged or sealed properly, it runs the risk that a product's expiration date is no longer accurate, and that the product could become contaminated. Maintaining packaging standards is important as it can make consumers feel more assured that companies have followed regulatory guidance more closely, and ensured their products are properly manufactured and controlled - particularly when concerns about food recalls are high in the U.S. File photo: pickles in a jar. File photo: pickles in a To Know The recall was initiated by Gedney Foods Company on June 9, and the FDA released its classification on July 24. The recalled products include: Gedney Ghost Pepper LIL Pickles, sized Net 24 fl oz, item number 75802, UPC 0 41660-00758 9, Lot Code 4283 Gedney's Zinger Pickle products, with sizes of Net 24 fl oz: Zinger Chips, item number 18800, UPC 0 41660-00188 4 Zingers Dill Babies, item number 18600, UPC 0 41660-00186 0, Lot Codes 4218 and 4269 Gedney's Dill Pickle products, in various sizes between Net 16 fl oz and Net 32 fl oz, with the majority of products Net 32 fl oz: Gedney Whole Pickles, item number 15100, UPC 0 41660-00151 8 Gedney Mini Munchers Kosher Dill, item number 17100, UPC 0 41660-00171 6 Gedney Kosher Dill Babies, item number 17200, UPC 0 41660-00172 3 Gedney Dill Mini Munchers, item number 17300, UPC 0 41660-00173 0 Gedney Dill Babies, item number 18400, UPC 0 41660-00184 6 Gedney Dill Babies, item number 19100, UPC 0 41660-00191 4 Gedney Kosher Dill Babies, item number 19200, UPC 0 41660-00192 1 Gedney Dill Spears, item number 19600, UPC 0 41660- 00196 9 Production and expiration dates of the products were not listed on the FDA's recall notices. With 3,520 cases, and 12 jars per case, involved in each recall, there is a significant number of products involved - all of which were distributed to consumers in Minnesota. All products were manufactured in Mexico and distributed by Burnsville-based Gedney Foods Company. The recall remains ongoing as of July 25, 2025, and no termination date has been set. What People Are Saying The FDA said on its website: "Food manufacturers are responsible for marketing safe foods. Ingredients added directly to food and substances that come into contact with food are generally held to the same safety standard—there must be a reasonable certainty of no harm under the conditions of its intended use." What Happens Next The FDA recommends that consumers in Minnesota who purchased the recalled Gedney Food Company pickle products check lot numbers against the FDA database and immediately stop consuming these products if affected. Damaged packaging can increase contamination risk, and even foods that appear safe may pose health hazards. Consumers should follow store return instructions or dispose of the affected items.
Washington Post
4 days ago
- Washington Post
Tracking Trump: Columbia University's deal; USDA is leaving DC; IRS looks to end non-English services; and more
Columbia University reached a deal with the White House. The USDA is leaving the Washington area. The Senate minority leader called for an Epstein files briefing. The IRS is considering ending multi-language services. ICE ordered staff to put GPS ankle monitors on immigrants. The White House denied disaster relief funds for Maryland floods. A federal appeals court ruled that Trump can't end birthright citizenship. Before you go … Health and Human Services Secretary Robert F. Kennedy Jr. is a longtime vaccine skeptic. His tenure at HHS has already changed how you access vaccines — here's how. Want to stay on top of President Trump's second term? Sign up for the newsletter to get the top stories every weeknight.
